Cullinan Associates Inc Bristol Myers Squibb CO Transaction History

Cullinan Associates Inc

  • $1.81 Billion
  • Q3 2024

A detailed history of Cullinan Associates Inc transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Cullinan Associates Inc holds 92,232 shares of BMY stock, worth $5.29 Million. This represents 0.26% of its overall portfolio holdings.

Number of Shares
92,232
Previous 105,556 12.62%
Holding current value
$5.29 Million
Previous $4.38 Million 8.9%
% of portfolio
0.26%
Previous 0.25%

Shares

29 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 23, 2024
SELL
$39.66 - $51.75 $528,429 - $689,517
-13,324 Reduced 12.62%
92,232 $4.77 Million
Q2 2024

Jul 10, 2024
SELL
$40.25 - $52.99 $152,225 - $200,408
-3,782 Reduced 3.46%
105,556 $4.38 Million
Q1 2024

Apr 18, 2024
SELL
$47.98 - $54.4 $237,309 - $269,062
-4,946 Reduced 4.33%
109,338 $5.93 Million
Q4 2023

Jan 24, 2024
SELL
$48.48 - $57.85 $1.26 Million - $1.51 Million
-26,085 Reduced 18.58%
114,284 $5.86 Million
Q3 2023

Oct 11, 2023
BUY
$57.89 - $64.73 $346,529 - $387,473
5,986 Added 4.45%
140,369 $8.15 Million
Q2 2023

Jul 14, 2023
SELL
$63.71 - $70.74 $1.88 Million - $2.08 Million
-29,439 Reduced 17.97%
134,383 $8.59 Million
Q1 2023

Apr 05, 2023
BUY
$65.71 - $74.53 $2.51 Million - $2.84 Million
38,134 Added 30.34%
163,822 $11.4 Million
Q4 2022

Jan 11, 2023
BUY
$68.48 - $81.09 $1.01 Million - $1.19 Million
14,710 Added 13.25%
125,688 $9.04 Million
Q3 2022

Oct 19, 2022
BUY
$0.13 - $76.84 $1,522 - $900,026
11,713 Added 11.8%
110,978 $7.89 Million
Q2 2022

Jul 08, 2022
SELL
$72.62 - $79.98 $178,427 - $196,510
-2,457 Reduced 2.42%
99,265 $7.64 Million
Q1 2022

Apr 21, 2022
SELL
$61.48 - $73.72 $10.8 Million - $12.9 Million
-175,510 Reduced 63.31%
101,722 $7.43 Million
Q4 2021

Jan 07, 2022
BUY
$53.63 - $62.52 $117,986 - $137,544
2,200 Added 0.8%
277,232 $17.3 Million
Q3 2021

Oct 08, 2021
BUY
$59.17 - $69.31 $429,870 - $503,537
7,265 Added 2.71%
275,032 $16.3 Million
Q2 2021

Jul 07, 2021
BUY
$61.91 - $67.42 $961,709 - $1.05 Million
15,534 Added 6.16%
267,767 $17.9 Million
Q1 2021

Apr 20, 2021
BUY
$59.34 - $66.74 $22,608 - $25,427
381 Added 0.15%
252,233 $15.9 Million
Q4 2020

Jan 14, 2021
SELL
$57.74 - $65.43 $753,911 - $854,319
-13,057 Reduced 4.93%
251,852 $15.6 Million
Q3 2020

Oct 09, 2020
SELL
$57.43 - $63.64 $518,592 - $574,669
-9,030 Reduced 3.3%
264,909 $16 Million
Q2 2020

Jul 07, 2020
BUY
$54.82 - $64.09 $35,358 - $41,338
645 Added 0.24%
273,939 $16.1 Million
Q1 2020

Apr 01, 2020
SELL
$46.4 - $67.43 $124,537 - $180,982
-2,684 Reduced 0.97%
273,294 $15.2 Million
Q4 2019

Jan 15, 2020
BUY
$49.21 - $64.19 $383,542 - $500,296
7,794 Added 2.91%
275,978 $17.7 Million
Q3 2019

Oct 01, 2019
BUY
$42.77 - $50.71 $3.3 Million - $3.91 Million
77,126 Added 40.37%
268,184 $13.6 Million
Q2 2019

Jul 16, 2019
BUY
$44.62 - $49.34 $2.63 Million - $2.91 Million
58,901 Added 44.57%
191,058 $8.66 Million
Q1 2019

Apr 30, 2019
BUY
$45.12 - $53.8 $2.48 Million - $2.95 Million
54,907 Added 71.08%
132,157 $6.31 Million
Q4 2018

Jan 11, 2019
SELL
$48.76 - $63.23 $202,354 - $262,404
-4,150 Reduced 5.1%
77,250 $4.02 Million
Q3 2018

Oct 19, 2018
SELL
$55.19 - $62.25 $347,697 - $392,175
-6,300 Reduced 7.18%
81,400 $5.05 Million
Q2 2018

Jul 09, 2018
SELL
$50.53 - $62.98 $1.54 Million - $1.92 Million
-30,500 Reduced 25.8%
87,700 $4.85 Million
Q1 2018

Apr 27, 2018
SELL
$59.92 - $68.98 $209,480 - $241,154
-3,496 Reduced 2.87%
118,200 $7.48 Million
Q4 2017

Jan 17, 2018
SELL
$59.94 - $65.35 $389,610 - $424,774
-6,500 Reduced 5.07%
121,696 $7.46 Million
Q3 2017

Oct 16, 2017
BUY
$55.23 - $63.74 $7.08 Million - $8.17 Million
128,196
128,196 $8.17 Million

Others Institutions Holding BMY

# of Institutions
2,536
Shares Held
1.47B
Call Options Held
31.6M
Put Options Held
35M
View Full List

About BRISTOL MYERS SQUIBB CO

BMY Quotes by TradingView
  • Ticker BMY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,126,160,000
  • Market Cap $122B
  • Description
  • Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...
More about BMY
Track This Portfolio

Track Cullinan Associates Inc Portfolio

Follow Cullinan Associates Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Cullinan Associates Inc, based on Form 13F filings with the SEC.

News

Stay updated on Cullinan Associates Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email